PMDA
- Application: Zilbrysq
- Local brand name: Zilbrysq
- Status: approved
Zilbrysq (Zilbrysq) regulatory status in Japan.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA has authorised it.
Centre Hospitalier Universitaire de Nice is the originator. The local marketing authorisation holder may differ — check the official source linked above.